Press release
Global Chlamydia Diagnosis and Treatment Market Research and Forecast 2018-2023
According to OMR analysis, the global chlamydia diagnosis market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The change in lifestyle especially related to sex preferences is the major factor driving the growth of this market, moreover, the increase in the use of rapid point of care diagnosis kits also propels the market. The treatment of this disease is prolonged and usually achieved by administration of oral antibiotics to the patients.
A full report of global Chlamydia diagnosis market is available at https://www.omrglobal.com/industry-reports/chlamydia-disease-diagnosis-treatment-market/
Furthermore, the global chlamydia diagnosis market is segmented on the basis of diagnosis methods, treatment approach, and end-user. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global Chlamydia Market by Diagnosis Methods
• Chlamydia Culture
• Urine Culture
• Enzyme Immunoassays
• Nucleic Acid Amplification Test
2. Global Chlamydia Market by Treatment Approach
• Oral Antibiotics
3. Global Chlamydia Diagnosis and Treatment Market by End-User
• Hospitals
• Diagnostic Centers
• Research Institutions
Region Covered
• North America (the US and Canada)
• Europe (the United Kingdom, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, Japan, and South Korea)
• Rest of the World (the Middle East & Africa and Latin America)
Company Profiled
• Abbott Laboratories, Inc.
• Aetna, Inc.
• Agilent Technologies
• Akers Biosciences, Inc.
• Bio-Rad Laboratories, Inc.
• Cigna
• Clinical Lab Product
• Diadexus, Inc.
• Erba Diagnostics
• Hologic, Inc.
• Laboratory Corporation Of America
• Novartis Diagnostics
• Qiagen
• Quidel Corp.
• Roche Molecular Systems, Inc.
• Siemens AG
• Synapse Diagnostics
• Sysmex Corp.
• Thermo Fisher Scientific
• Tosoh Corp.
For related reports please visit https://www.omrglobal.com/reports-category/healthcare/
For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Chlamydia Diagnosis and Treatment Market Research and Forecast 2018-2023 here
News-ID: 1637870 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Chlamydia
Chlamydia Diagnosis And Treatment Market Size Analysis by Application, Type, and …
According to Market Research Intellect, the global Chlamydia Diagnosis And Treatment market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for chlamydia diagnosis and treatment is expanding rapidly as a result of improvements in…
Preventive Healthcare Boosts Growth of Chlamydia Diagnostics Market Driver: Lead …
How Are the key drivers contributing to the expansion of the chlamydia infection diagnostics market?
The emphasis on preventive healthcare is anticipated to drive the growth of the chlamydia infection diagnostics market. Rather than treating diseases after their occurrence, preventive healthcare focuses on their prevention through consistent medical check-ups, immunizations, and changes in lifestyle. The goal is to lessen the cost of healthcare, enhance the quality of life, and keep chronic…
Key Trend Reshaping the Chlamydia Infection Diagnostics And Therapeutics Market …
What Are the Projections for the Size and Growth Rate of the Chlamydia Infection Diagnostics And Therapeutics Market?
In recent times, the market size for chlamydia infection diagnostics and therapeutics has seen a robust expansion. The projected growth is from $1.43 billion in 2024 to $1.51 billion in 2025, representing a CAGR of 5.9%. The historic growth has been influenced by factors such as a rise in sexual activity, enhancement in…
Chlamydia Diagnostic Market Analysis and Forecast 2024
"The Business Research Company recently released a comprehensive report on the Global Chlamydia Infection Diagnostics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Chlamydia Pneumoniae Antibody Market: Rising Prevalence of Chlamydia Pneumoniae …
Global Chlamydia Pneumoniae Antibody Market Overview:
The Chlamydia Pneumoniae Antibody market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Chlamydia Pneumoniae Antibody market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…
Chlamydia Infections-Pipeline Review H2 2018
Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in the lower abdomen, bleeding between periods and pain and swelling around the testicles. Predisposing factors include age, multiple sex partners and history of prior sexually transmitted infection. Treatment includes antibiotics and pain medicine.
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Chlamydia Infections-Pipeline Review, H2 2018,…
